Immucell (ICCC) Non-Current Assets (2010 - 2026)

Immucell (ICCC) has reported Non-Current Assets for 17 consecutive years, with $25.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets rose 0.6% year-over-year to $25.5 million; the trailing twelve-month figure through Jun 2026 stood at $105.4 million (down 8.88% YoY), and the FY2025 full-year result was $25.6 million, down 14.87% from the prior year.
• Non-Current Assets was little changed at $25.5 million in Q2 2026 per ICCC's latest filing, from $25.6 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $33.1 million in Q2 2023 and bottomed at $25.4 million in Q2 2025.
• Historically, Non-Current Assets has averaged $29.7 million across 5 years, with a median of $30.1 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Non-Current Assets grew 15.38% in 2023, then dropped 18.24% in 2025.
• Over 5 years, Non-Current Assets stood at $30.9 million in 2022, then climbed by 4.77% to $32.3 million in 2023, then fell by 7.05% to $30.1 million in 2024, then fell by 14.87% to $25.6 million in 2025, then slipped by 0.15% to $25.5 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $25.5 million, $25.6 million, and $28.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.